PT110585A - Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização - Google Patents

Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Info

Publication number
PT110585A
PT110585A PT11058518A PT11058518A PT110585A PT 110585 A PT110585 A PT 110585A PT 11058518 A PT11058518 A PT 11058518A PT 11058518 A PT11058518 A PT 11058518A PT 110585 A PT110585 A PT 110585A
Authority
PT
Portugal
Prior art keywords
atomization
drying
solution
particulars
suspension
Prior art date
Application number
PT11058518A
Other languages
English (en)
Other versions
PT110585B (pt
Inventor
Temtem Marcio
Vicente João
Sá Couto Clara
Ferreira Rui
Original Assignee
Hovione Farm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Farm Sa filed Critical Hovione Farm Sa
Priority to PT110585A priority Critical patent/PT110585B/pt
Priority to IL276826A priority patent/IL276826B1/en
Priority to AU2019224665A priority patent/AU2019224665B2/en
Priority to EP19710471.4A priority patent/EP3755307B1/en
Priority to JP2020544414A priority patent/JP7481259B2/ja
Priority to CN201980025054.4A priority patent/CN111954520A/zh
Priority to PCT/GB2019/050495 priority patent/WO2019162688A1/en
Priority to US16/971,789 priority patent/US11752105B2/en
Priority to CA3091546A priority patent/CA3091546A1/en
Priority to KR1020207026942A priority patent/KR20200123452A/ko
Publication of PT110585A publication Critical patent/PT110585A/pt
Publication of PT110585B publication Critical patent/PT110585B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/005—Drying solid materials or objects by processes not involving the application of heat by dipping them into or mixing them with a chemical liquid, e.g. organic; chemical, e.g. organic, dewatering aids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A PRESENTE INVENÇÃO APRESENTA UM PROCESSO DE SECAGEM POR ATOMIZAÇÃO CARACTERIZADO PELA PREPARAÇÃO CONTÍNUA E SECAGEM POR ATOMIZAÇÃO IMEDIATA DE UMA SOLUÇÃO COMPREENDENDO PELO MENOS UM INGREDIENTE FARMACÊUTICO ATIVO E / OU PELO MENOS UM EXCIPIENTE, E PELO MENOS UM SOLVENTE. O(S) REFERIDO(S) INGREDIENTE(S) FARMACÊUTICO(S) ATIVO(S) E/OU EXCIPIENTE(S) E SOLVENTE(S) SÃO COMBINADOS, SOZINHOS OU JUNTAMENTE COM UM OU MAIS EXCIPIENTES PARA FORMAR UMA PRIMEIRA SUSPENSÃO. A REFERIDA SUSPENSÃO É CONTINUAMENTE ALIMENTADA A UMA BOMBA INTENSIFICADORA QUE EMPURRA A REFERIDA SUSPENSÃO ATRAVÉS DE PELO MENOS UMA CÂMARA DE MICRO-REACÇÃO E / OU PELO MENOS UM MICROCANAL ONDE O(S) COMPONENTE(S) SÓLIDO(S) DA SUSPENSÃO É(SÃO) DISSOLVIDO(S) NO REFERIDO SOLVENTE(S) POR MEIO DE MISTURA DE ELEVADA ENERGIA / CONTATO FORÇADO A NÍVEL MICRO, NANO E MOLECULAR PARA FORMAR UMA CORRENTE DE SOLUÇÃO. ESTA CORRENTE DE SOLUÇÃO É ALIMENTADA DE IMEDIATO E DE FORMA CONTINUA AO SECADOR POR ATOMIZAÇÃO ATRAVÉS DE PELO MENOS UM ATOMIZADOR, SENDO SECA DE FORMA A OBTER PARTÍCULAS SÓLIDAS E RECOLHENDO AS DITAS PARTÍCULAS SÓLIDAS. PARTÍCULAS DE COMPONENTE ÚNICO, OU PARTÍCULAS DE COMPONENTES MÚLTIPLOS, PARTÍCULAS DE DISPERSÕES SÓLIDAS AMORFAS E COMPOSIÇÕES FARMACÊUTICAS SÃO TAMBÉM APRESENTADAS. A PRESENTE INVENÇÃO TAMBÉM APRESENTA DISPERSÕES SÓLIDAS AMORFAS OBTIDAS PELO MÉTODO DA INVENÇÃO, BEM COMO COMPOSIÇÕES FARMACÊUTICAS CONTENDO AS MESMAS.
PT110585A 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização PT110585B (pt)

Priority Applications (10)

Application Number Priority Date Filing Date Title
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
IL276826A IL276826B1 (en) 2018-02-22 2019-02-22 Spray drying process with continuous preparation of spray solution
AU2019224665A AU2019224665B2 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
EP19710471.4A EP3755307B1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
JP2020544414A JP7481259B2 (ja) 2018-02-22 2019-02-22 スプレー溶液の連続調整を伴うスプレードライプロセス
CN201980025054.4A CN111954520A (zh) 2018-02-22 2019-02-22 连续制备喷雾溶液的喷雾干燥方法
PCT/GB2019/050495 WO2019162688A1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
US16/971,789 US11752105B2 (en) 2018-02-22 2019-02-22 Spray drying process with continuous preparation of spray solution
CA3091546A CA3091546A1 (en) 2018-02-22 2019-02-22 A spray drying process with continuous preparation of spray solution
KR1020207026942A KR20200123452A (ko) 2018-02-22 2019-02-22 분무 용액의 연속적인 제조를 사용한 분무 건조 방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Publications (2)

Publication Number Publication Date
PT110585A true PT110585A (pt) 2019-08-22
PT110585B PT110585B (pt) 2021-04-22

Family

ID=65729388

Family Applications (1)

Application Number Title Priority Date Filing Date
PT110585A PT110585B (pt) 2018-02-22 2018-02-22 Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Country Status (10)

Country Link
US (1) US11752105B2 (pt)
EP (1) EP3755307B1 (pt)
JP (1) JP7481259B2 (pt)
KR (1) KR20200123452A (pt)
CN (1) CN111954520A (pt)
AU (1) AU2019224665B2 (pt)
CA (1) CA3091546A1 (pt)
IL (1) IL276826B1 (pt)
PT (1) PT110585B (pt)
WO (1) WO2019162688A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11752105B2 (en) 2018-02-22 2023-09-12 Hovione Scientia Limited Spray drying process with continuous preparation of spray solution

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5222807A (en) 1991-03-12 1993-06-29 Gaco Manufacturing Division Of Gaddis Petroleum Corporation Low shear polymer dissolution apparatus
FI98892C (fi) 1994-11-15 1997-09-10 Turun Asennusteam Oy Polymeerien liuotusmenetelmä ja -laite
EP1011856B1 (en) 1997-08-05 2003-04-09 Microfluidics International Corporation Multiple stream high pressure mixer/reactor
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
JP5484910B2 (ja) 2006-12-22 2014-05-07 ユーハン・コーポレイション レバプラザン含有の固体分散体及びその製造方法
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
EP3130396B1 (en) 2009-03-27 2021-03-17 Bend Research, Inc. Spray-drying process
CA2904587C (en) 2013-03-14 2021-01-12 Ecolab Usa Inc. Polymer dissolution system
CA2939342A1 (en) 2014-02-11 2015-08-20 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
EP3166986B1 (en) * 2014-07-10 2023-04-19 Huntsman Petrochemical LLC A composition to reduce the amount of aldehydes emitted from polyurethane foams
PT107846B (pt) * 2014-08-01 2019-03-22 Hovione Farm S A Produção de nano- partículas de dispersões sólidas amorfas por co-precipitação controlada
US9432572B2 (en) * 2014-12-01 2016-08-30 Here Global B.V. Method and apparatus for automatic prediction of dynamic exposure
PT108368B (pt) 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
PT109117B (pt) * 2016-01-28 2019-02-01 Hovione Farm Sa Complexação de ingredientes ativos farmacêuticos
PT110585B (pt) 2018-02-22 2021-04-22 Hovione Farmaciencia Sa Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11752105B2 (en) 2018-02-22 2023-09-12 Hovione Scientia Limited Spray drying process with continuous preparation of spray solution

Also Published As

Publication number Publication date
CA3091546A1 (en) 2019-08-29
EP3755307A1 (en) 2020-12-30
IL276826A (en) 2020-10-29
PT110585B (pt) 2021-04-22
AU2019224665B2 (en) 2024-09-05
JP7481259B2 (ja) 2024-05-10
US20210077405A1 (en) 2021-03-18
EP3755307B1 (en) 2023-08-23
CN111954520A (zh) 2020-11-17
IL276826B1 (en) 2024-10-01
WO2019162688A1 (en) 2019-08-29
US11752105B2 (en) 2023-09-12
JP2021514954A (ja) 2021-06-17
KR20200123452A (ko) 2020-10-29
EP3755307C0 (en) 2023-08-23
AU2019224665A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
UY37435A (es) Pirrolidinas sustituidas y métodos para usarlas
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
MY171305A (en) Production method for readily dispersible cellulose composition, readily dispersible cellulose composition, cellulose dispersion resin composition, and production method for water-based dispersant for cellulose
BR112019003287A2 (pt) processo para sintetizar uma cetona interna k1, uso da cetona interna k1, e, método para preparar um composto a partir de uma cetona interna k1
CL2017003067A1 (es) Piridinas sustituidas y método de uso
AR102916A1 (es) Sistema de suministro nano particulado
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
CL2018003178A1 (es) Composición farmacéutica
BR112015019432A2 (pt) Compostos de tubulisina, métodos de produção e uso
BR112017013691A2 (pt) composição compreendendo um polímero em multiestágio, seu método de preparação e seu uso
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
EA201890704A1 (ru) Способы получения стабильных терапевтических составов в апротонных полярных растворителях
MY177820A (en) Controlled release peptide formulations
PT110585A (pt) Processo de produção contínua de partículas compreendendo secagem por atomização com preparação contínua da solução de atomização
BR102015030626B8 (pt) Composições de dispersão de poliolefina para preparar revestimentos hidrofóbicos de transporte de vapor alto
Shakeel et al. Thermodynamics of solubility of isatin in Carbitol+ water mixed solvent systems at different temperatures
BR112018077433A2 (pt) processo para preparação de polímeros de ácido acrílico sólidos, e, solução aquosa de polímero de ácido acrílico pelo menos parcialmente neutralizada .
BR112017019750A2 (pt) processo para preparação de uma forma cristalina de menaquinol, forma cristalina de menaquinol, processo para preparação de uma forma sólida do menaquinol, composição farmacêutica ou nutracêutica e uso da forma cristalina de menaquinol
BR112019003175A2 (pt) métodos para determinar o potencial de uma proteína para se auto-associar e para preparar uma formulação farmacêutica de baixa viscosidade contendo uma proteína, e, mistura bioanalítica.
BR112023000467A2 (pt) Tensoativos de aminoácidos ramificados para tintas, tintas para pintura e adesivos
BR112018077063A2 (pt) sistema misturador para produção de composições aquosas de revestimento reparador, composição aquosa de revestimento reparador, método para produção de composições de revestimento reparador, e, uso do sistema misturador.
BR112018067918A2 (pt) formulações livres de solvente de substâncias ativas com baixo ponto de fusão
BR112018009618A2 (pt) processo para fabricação de uma dispersão aquosa compreendendo farelo de mostarda, emulsão de óleo em água e processo de fabricação de uma emulsão de óleo em água
BR112019006009A2 (pt) método não terapêutico, partícula ou composição e uso
BR112018007692A2 (pt) processo de produção de 5-hidroximetilfurfural na presença de catalisadores da família de ácidos sulfônicos homogêneos na presença de pelo menos um solvente polar aprótico

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20190626

FG3A Patent granted, date of granting

Effective date: 20210420